chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 39.0
Sex: F
Vaccine: FLUC4
Symptoms: Pyrexia, Swelling of eyelid, Urticaria
Clinical narrative: I went to pharmacy to get my yearly flu shot for work. As I left the store I felt head-achy and slightly light headed. On my drive home the head ache got worse and body aches developed. By the time I got home (about 20 min.after the vaccine) I felt feverish and fatigued. I did not take my temperature because i could not find the thermometer. As I looked for the thermometer I noticed I had hives on my arms and chest. later that afternoon I noticed my eyes were puffy and a numb/dry mouth sensation so I took Benadryl. The next day the Hives and puffiness were gone. I took my vaccine confirmation to work. The Nurse practitioner on site suggested that I file a Vaers report.
Age: 0.5
Sex: F
Vaccine: DTAP, HIBV, PNC13
Symptoms: Chills, Irritability, Pyrexia, Vomiting
Clinical narrative: Fever, chills, irritability, and vomiting.
Age: 93.0
Sex: F
Vaccine: VARZOS
Symptoms: Product preparation error
Clinical narrative: THE PHARMACIST USED THE DILUENT FROM ZOSTAVAX NDC00006430901 TO MIX WITH SHINGRIX AND ADMINISTERED TO PATIENT.
Age: 24.0
Sex: F
Vaccine: DTAP, HPV9
Symptoms: Dizziness
Clinical narrative: Dizziness for 1 day, body temperature 37.0 degrees Celsius.
Age: 71.0
Sex: F
Vaccine: VARZOS
Symptoms: Adverse event, Dizziness, Peripheral swelling
Clinical narrative: Patient stated that she had swelling in her arm. She felt dizzy the day after the injection and went to her doctor. The doctor suspected this reaction to be an adverse event.
Age: 66.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Arthralgia, Chills, Dizziness, Fatigue, Immediate post-injection reaction
Clinical narrative: Redness at injection site appeared immediately. Patient came home and began experiencing dizziness, low grade fever, chills, shivering, fatigue, and joint pain. Next day, 2/14/19, a painful area of about  5x3 inch appeared to be swollen, red and raised around the injection site.
Age: 66.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Pyrexia
Clinical narrative: Redness at injection site appeared immediately. Patient came home and began experiencing dizziness, low grade fever, chills, shivering, fatigue, and joint pain. Next day, 2/14/19, a painful area of about  5x3 inch appeared to be swollen, red and raised around the injection site.
Age: 66.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Adverse drug reaction, Incorrect route of product administration
Clinical narrative: Redness at injection site appeared immediately. Patient came home and began experiencing dizziness, low grade fever, chills, shivering, fatigue, and joint pain. Next day, 2/14/19, a painful area of about  5x3 inch appeared to be swollen, red and raised around the injection site.
Age: 73.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Dizziness, Fatigue, Headache, Injection site erythema
Clinical narrative: About 8:30 PM, the back of my neck started hurting which then spread across to each shoulder and down both arms and spine. By 8:50 I developed a headache, fever, shivers and dizziness. These lasted until 1 AM. I then slept until 8 AM but for the next whole day I was exhausted. After sleeping that night I was back to normal with the exception of the injection still being inflamed, swollen and hot and after 4 days and 12 hours, it still is very pink and warm to the touch.
Age: 73.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site inflammation, Injection site pain, Injection site swelling, Injection site warmth, Musculoskeletal pain
Clinical narrative: About 8:30 PM, the back of my neck started hurting which then spread across to each shoulder and down both arms and spine. By 8:50 I developed a headache, fever, shivers and dizziness. These lasted until 1 AM. I then slept until 8 AM but for the next whole day I was exhausted. After sleeping that night I was back to normal with the exception of the injection still being inflamed, swollen and hot and after 4 days and 12 hours, it still is very pink and warm to the touch.
Age: 73.0
Sex: F
Vaccine: VARZOS
Symptoms: Neck pain, Pain in extremity, Pyrexia, Spinal pain
Clinical narrative: About 8:30 PM, the back of my neck started hurting which then spread across to each shoulder and down both arms and spine. By 8:50 I developed a headache, fever, shivers and dizziness. These lasted until 1 AM. I then slept until 8 AM but for the next whole day I was exhausted. After sleeping that night I was back to normal with the exception of the injection still being inflamed, swollen and hot and after 4 days and 12 hours, it still is very pink and warm to the touch.
Age: 53.0
Sex: F
Vaccine: VARZOS
Symptoms: Axillary pain, Dizziness, Lymph node pain, Lymphadenopathy, Mammogram normal
Clinical narrative: Vaccination was uneventful. Day after felt slight nausea and little dizzy/off with increasing pain in left axilla - mild swelling and tender lymphnodes on palpation. Recent mammogram was normal. No other lesions on arm or chest to explain unilateral lymphandenopathy.
Age: 53.0
Sex: F
Vaccine: VARZOS
Symptoms: Nausea
Clinical narrative: Vaccination was uneventful. Day after felt slight nausea and little dizzy/off with increasing pain in left axilla - mild swelling and tender lymphnodes on palpation. Recent mammogram was normal. No other lesions on arm or chest to explain unilateral lymphandenopathy.
Age: 0.17
Sex: F
Vaccine: DTAPIPVHIB, HEP, PNC13, RV5
Symptoms: No adverse event, Product preparation issue
Clinical narrative: Vaccine diluent was administered without antigen. MA did not complete reconstitution with Antigen Powder. Upon monthly logs discovered this. Will need to administer another PENTACEL at 8mo. Notified mother and father of issue on 1/28/19 PENTACEL Administration where training MA under supervision of clinical MA and MD. Failed to reconstitute diluent with Antigen powder for PENTACEL. So inadvertently diluent was administered without Antigen. Pt did not received adequate IPV-Hib-DTaP dose protection as needed. But no adverse effect of the diluent administered. Discussed with mother/father and will administered PENTACEL at 4, 6, 8 months age to give full protection.
Age: 0.33
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV5
Symptoms: Chest X-ray, Epistaxis, Full blood count, Influenza A virus test, Influenza B virus test
Clinical narrative: This young lady just had her immunization shots yesterday and today mother found her with some red substance coming from her nose that she thought was blood and she had "stopped breathing" so she brought her to the ER immediately in her car. When she got to the emergency room the baby was breathing fine no problems with respirations. She was quite asleep and was a hard time getting her awake but when she was awake she was alert and breathing quite well.
Age: 0.33
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV5
Symptoms: Metabolic function test, Respiratory arrest, Somnolence, Urine analysis
Clinical narrative: This young lady just had her immunization shots yesterday and today mother found her with some red substance coming from her nose that she thought was blood and she had "stopped breathing" so she brought her to the ER immediately in her car. When she got to the emergency room the baby was breathing fine no problems with respirations. She was quite asleep and was a hard time getting her awake but when she was awake she was alert and breathing quite well.
Age: 44.0
Sex: F
Vaccine: HEPA
Symptoms: Anxiety, Cold sweat, Immediate post-injection reaction, Loss of consciousness
Clinical narrative: Patient appeared nervous to be receiving vaccine. Immediately after receiving the vaccine, patient said she felt clammy. She asked me if she looked pale. Then she told me that she thought she was going to pass out. The patient then passed out. Her head was on my arm. I called for help from a technician. Checked that patient had a pulse and was breathing. She was. Technician called 911. Patient was out for maybe 30 seconds. She was alert and responsive to all our questions. The paramedics arrived and evaluated her. The paramedics said it was caused by anxiety about receiving a vaccine. I checked patients BP it was 119/80. Patient declined to go to with paramedics. We called patients family and waited. Update: Patients husband came by pharmacy and reported that patient was fine. They took her to ER and said that the MD told them that patient passed out due to anxiety about the vaccine. She has been released and is fine. 2-19-19 at 1pm.
Age: 2.0
Sex: M
Vaccine: FLUX
Symptoms: Pruritus generalised, Urticaria
Clinical narrative: Total body itchy hives started same day as vaccine. Mild. Scattered. Persisted since that day. No prior Hx. No other assoc. symptoms. (Parent reports not relieved by OTC BENADRYL. Pending resolution: prednisolone prescribed. (This was second flu vaccine).
Age: 59.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Headache, Malaise, Muscle spasms, Nausea
Clinical narrative: Patient received the vaccine on 02/15/19 around 7:20 pm and started feeling chills and general malaise and strong back spasm, she also developed nausea/vomiting, headache and shakiness along with that. Patient stated it last for about 2 days and she was better by 02/18/2019.
Age: 59.0
Sex: F
Vaccine: VARZOS
Symptoms: Tremor, Vomiting
Clinical narrative: Patient received the vaccine on 02/15/19 around 7:20 pm and started feeling chills and general malaise and strong back spasm, she also developed nausea/vomiting, headache and shakiness along with that. Patient stated it last for about 2 days and she was better by 02/18/2019.
Age: 59.0
Sex: M
Vaccine: VARZOS, VARZOS
Symptoms: Blister, Pruritus
Clinical narrative: This case was reported by a pharmacist via call center representative and described the occurrence of blister in a 59-year-old male patient who received SHINGRIX (batch number JE45P, expiry date 29th May 2021) for prophylaxis. On 8th February 2019, the patient received the 1st dose of SHINGRIX (intramuscular). On 9th February 2019, 1 days after receiving SHINGRIX, the patient experienced blister. On an unknown date, the outcome of the blister was not recovered/not resolved. It was unknown if the reporter considered the blister to be related to SHINGRIX. Additional details were provided as follows: The patient received SHINGRIX on left arm. The patient experienced blisters on left palm one day after receiving SHINGRIX. The reporter asked the patient if the blisters were anywhere else, and the patient said he saw two blisters on right palm.
Age: 59.0
Sex: M
Vaccine: VARZOS, VARZOS
Symptoms: Blister
Clinical narrative: This case was reported by a pharmacist via call center representative and described the occurrence of blister in a 59-year-old male patient who received SHINGRIX (batch number JE45P, expiry date 29th May 2021) for prophylaxis. On 8th February 2019, the patient received the 1st dose of SHINGRIX (intramuscular). On 9th February 2019, 1 days after receiving SHINGRIX, the patient experienced blister. On an unknown date, the outcome of the blister was not recovered/not resolved. It was unknown if the reporter considered the blister to be related to SHINGRIX. Additional details were provided as follows: The patient received SHINGRIX on left arm. The patient experienced blisters on left palm one day after receiving SHINGRIX. The reporter asked the patient if the blisters were anywhere else, and the patient said he saw two blisters on right palm.
Age: 52.0
Sex: M
Vaccine: VARZOS, VARZOS
Symptoms: Herpes zoster, Musculoskeletal pain, Pain in extremity
Clinical narrative: Severe soreness in arm/shoulder for 3 days and then developed shingles on chest and back.
Age: 52.0
Sex: M
Vaccine: VARZOS, VARZOS
Symptoms: Herpes zoster, Rash, Rash erythematous
Clinical narrative: Severe soreness in arm/shoulder for 3 days and then developed shingles on chest and back.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Rash, Rash morbilliform, Swollen tongue
Clinical narrative: Measles like rash covering neck and torso. Expanded to face and arms over next 24 hours. Partial tongue swelling on left front of tongue beginning 02/20/2019 at approximately 2:00 AM.
Age: 25.0
Sex: M
Vaccine: ANTH
Symptoms: Unevaluable event
Clinical narrative: None stated.
Age: 22.0
Sex: M
Vaccine: ANTH
Symptoms: Unevaluable event
Clinical narrative: None.
Age: 58.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Pyrexia, Tremor
Clinical narrative: After second shot, both myself and my husband had a spike of fever, chills and major shaking about 11-12 hours after the shot. The shaking lasted about 30 minutes, did take ibuprofen. Fever lasted about 5-6 hours.
Sex: F
Vaccine: PPV
Symptoms: Adverse drug reaction, Cellulitis, Rash
Clinical narrative: This spontaneous report was received from a nurse prescriber refers to a 75-year-old female patient. Patient's pertinent medical history/drug allergies, concurrent diseases and concomitant therapies were not reported. On an unknown date in February 2017 (also reported as 2 years ago), the patient was vaccinated with PNEUMOVAX 23 1 dosage form for prevention of pneumonia (prophylaxis). Other suspect therapies included antimicrobial (unspecified) for treatment of cellulitis-like rash. On an unknown date in February 2017 (onset date reported as 2 years ago) the patient experienced cellulitis like reaction in the unspecified arm the vaccine was administered, which was spread to the chest. Then the patient sought for medical attention by attending to emergency room at hospital. The patient received treatment for event of cellulitis like rash with an unspecified antibiotic and developed an unspecified reaction to the antibiotic (adverse drug reaction). No product quality issues involved in this case. The outcome of events cellulitis and adverse drug reaction was reported as recovered. The reporter considered adverse drug reaction to be not related to PNEUMOVAX 23. The causality assessment was not provided for cellulitis. Upon internal review, the event cellulitis was determined to be medically significant.
Sex: U
Vaccine: HEPA
Symptoms: No adverse event, Product storage error
Clinical narrative: This spontaneous report was received from an physician and refers to a patient of unknown age and gender. Their concurrent conditions, medical history and concomitant therapies were not reported. On 13-FEB-2019, the patient was vaccinated with improperly stored dose of VAQTA (exact dose, dose number, route and site of administration were not reported) lot# R010369, expiry date 25-MAR-2019 for prophylaxis. The vaccine was exposed to temperature below 36 degrees Fahrenheit (33.6 degrees Fahrenheit) for 2 hours 37 minutes and digital data logger was involved. There were no previous temperature excursions reported. No adverse effects were reported.
Sex: U
Vaccine: RV5
Symptoms: No adverse event, Product storage error
Clinical narrative: This spontaneous report was received from a Registered Nurse concerning multiple patients of unknown age and gender. No pertinent medical history, drug reactions/ allergies or concurrent conditions were reported. On unspecified dates, the patients were vaccinated with an improperly stored dose of ROTATEQ lot# R002806; expiration date 29-SEP-2019 orally (dose and route of administration were not provided) for prophylaxis, which had a temperature excursion of 21.7°C for 8 hours and 30 minutes with no previous temperature excursions. Digital data logger was involved in recording the temperature excursion. No adverse effects were reported.
Sex: U
Vaccine: MMRV
Symptoms: Expired product administered
Clinical narrative: This spontaneous report was received from a registered nurse refers to a patient of unknown age and gender. Information on pertinent medical history, drug reactions/allergies and concomitant medications were not reported. On 15-FEB-2019, the patient was inadvertently vaccinated with an expired dose of PROQUAD subcutaneously for prophylaxis (dose, strength, dose number, vaccination site, #lot, expiry date unspecified) along with a sterile diluent (dosing details unspecified). Product quality complaint (PQC) was not reported.
Sex: F
Vaccine: VARZOS
Symptoms: Sinusitis
Clinical narrative: This case was reported by a consumer via patient support programs and described the occurrence of sinus infection in a female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received SHINGRIX .5 ml. On an unknown date, unknown after receiving SHINGRIX, the patient experienced sinus infection. On an unknown date, the outcome of the sinus infection was unknown. The reporter considered the sinus infection to be unrelated to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient was complaining about GSK asking questions of them during an earlier adverse event call. The patient had explained that if they tell us they were sick or went into the hospital GSK would like to follow up with a letter about the event and it was required of me to ask those questions. You do not had to answer if you do not want to. They proceeded to say they do not think their sinus infection had anything to do with the vaccine and ended the call.
Age: 54.0
Sex: F
Vaccine: VARZOS
Symptoms: Cough
Clinical narrative: This case was reported by a pharmacist via call center representative and described the occurrence of cough in a 54-year-old female patient who received SHINGRIX (batch number A4D72, expiry date 23rd May 2021) for prophylaxis. On 8th February 2019, the patient received the 2nd dose of SHINGRIX (intramuscular) .5 ml. In February 2019, less than a day after receiving SHINGRIX, the patient experienced cough. On an unknown date, the outcome of the cough was not recovered/not resolved.  It was unknown if the reporter considered the cough to be related to SHINGRIX. Additional details were provided as follows: The Pharmacist stated one of the patient's was administered second dose of the SHINGRIX vaccine. The night of vaccination patient started experiencing a cough that did not go away. No further details were provided.
Sex: F
Vaccine: VARZOS
Symptoms: Adverse event
Clinical narrative: This case was reported by a pharmacist via call center representative and described the occurrence of adverse event in a female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, unknown after receiving SHINGRIX, the patient experienced adverse event. On an unknown date, the outcome of the adverse event was unknown. It was unknown if the reporter considered the adverse event to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The pharmacist reported that the patient had a bad reaction and was afraid of receiving the 2nd dose of SHINGRIX. The pharmacist declined to provide additional details as the patient was vaccinated at the different location. No further information was available.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: This case was reported by a consumer via call center representative and described the occurrence of suspected vaccination failure in an unspecified number of adult patients who received SHINGRIX for prophylaxis. On an unknown date, the patient received SHINGRIX. On an unknown date, unknown after receiving SHINGRIX, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but was selected as adult as per product indication. The reporter stated that, she had heard of people getting shingles after receiving SHINGRIX. The reporter would not provide any contact information and disconnected before anything could be clarified. The reporter herself had not received SHINGRIX. This case was considered as suspected vaccination failure as the details regarding vaccination schedule and time to onset for the event were unknown. This case has been linked to the case US2019GSK030926, reported by same reporter.
Sex: F
Vaccine: MENB, MNQ
Symptoms: Head injury, Loss of consciousness
Clinical narrative: Initial information received on 13-Feb-2019 regarding an unsolicited valid serious case received from a nurse via company representative through other company (Pfizer) under reference number:  2018526562 (Manufacturer Report Number). This case involves a female patient of unknown age (the patient is a teenager)  who passed out and hit her head on something, after she received vaccines) MENACTRA (prefilled syringe) and TRUMENBA (prefilled syringe). Patient had not received any concomitant therapy nor she was having any past medical history. On an unknown date, the patient received a dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE lot number not reported via unknown route in unknown administration site. On an unknown date, the patient received a dose of suspect TRUMENBA not produced by Sanofi Pasteur lot number not reported via unknown route in unknown administration site. On an unknown date, the patient had passed out and hit her head on something (loss of consciousness and head injury) following the administration of MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE andTRUMENBA. This event(loss of consciousness) was assessed as medically significant (IME). No lab test was performed. Final diagnosis was loss of consciousness and head injury. It was not reported if the patient received a corrective treatment. The patient outcome was not reported. List of documents held by sender: none.; Sender's Comments: A female patient of unknown age experienced loss of consciousness  and head injury after vaccination with MENACTRA and TRUMENBA.Time to onset is unknown. Patient was not taking any concomitant medication and did not have any medical history. No laboratory investigation was performed. However, further information including, previous vaccination, physical condition at the time of vaccination and tolerance excluding other etiology would be needed to fully assess this case. Based on available information the role of individual vaccine cannot be assessed.
Age: 57.0
Sex: F
Vaccine: VARZOS
Symptoms: Asthenia, Fatigue, Injection site pain
Clinical narrative: As with the first shot patient experienced fatigue and weakness for two days following the vaccine.  There was also pain around the site of the injection that lasted for more than two days.
Age: 85.0
Sex: F
Vaccine: VARZOS
Symptoms: Fatigue, Hypoaesthesia
Clinical narrative: Patient reported feeling left side numbness and feeling very tired for approximately 24 hours.
Age: 22.0
Sex: M
Vaccine: FLUC4
Symptoms: Syncope
Clinical narrative: Patient fainted after getting vaccine and was coming to pick up window to collect the paper work. After few minutes he was fine,  talking and also get up and sit in our waiting area, drink water (almost full bottle). We let him wait for caregiver to pick him up and make sure he is not driving by accompany him upto the car.
Age: 11.0
Sex: M
Vaccine: HPV9, MNQ, TDAP
Symptoms: Burning sensation, Erythema, Oedema, Rash, Rash pruritic
Clinical narrative: Pt's mom states that on 2-15-19, at 4:30 pm, pt received vaccines at Health Dept. At approx 8:00pm, when pt went to bed, noticed redness, mostly to right side. On 2-16-19 upon wakening pt, right eye swollen shut, with redness and itching rash to right side. Rash was noticed from waist up. Mother verbalized that pt did have some redness and edema to left side, but more so on the right. Mother verbalized rash was itching and burning when scratched. Mom began giving pt Benadryl 25mg Q4H while awake, continued with Q4H Benadryl until seeing M.D. on 2-18-19. Pt was then given Decadron 3mg IM, and Kenalog 30mg IM, zantac 150mg bid, and prednisone 20 mg bid x 3 days. Spoke with mom on 2-20-19, mom verbalized rash is better, but still present, eyes are no longer swollen shut, and pt to follow up with M.D on 2-21-19.
Age: 11.0
Sex: M
Vaccine: HPV9, MNQ, TDAP
Symptoms: Swelling of eyelid
Clinical narrative: Pt's mom states that on 2-15-19, at 4:30 pm, pt received vaccines at Health Dept. At approx 8:00pm, when pt went to bed, noticed redness, mostly to right side. On 2-16-19 upon wakening pt, right eye swollen shut, with redness and itching rash to right side. Rash was noticed from waist up. Mother verbalized that pt did have some redness and edema to left side, but more so on the right. Mother verbalized rash was itching and burning when scratched. Mom began giving pt Benadryl 25mg Q4H while awake, continued with Q4H Benadryl until seeing M.D. on 2-18-19. Pt was then given Decadron 3mg IM, and Kenalog 30mg IM, zantac 150mg bid, and prednisone 20 mg bid x 3 days. Spoke with mom on 2-20-19, mom verbalized rash is better, but still present, eyes are no longer swollen shut, and pt to follow up with M.D on 2-21-19.
Age: 14.0
Sex: F
Vaccine: HPV9
Symptoms: Alopecia, Anti-thyroid antibody, Anti-thyroid antibody negative, Arthralgia, Blood 25-hydroxycholecalciferol
Clinical narrative: Two weeks after my first dose of the GARDASIL, I started not feeling good. I became extremely irritable and exhausted. This continued and intensified after my second dose. By the time I received the third dose of GARDASIL, my hair was starting to fall out of my head, I was getting joint pain and muscle aches, moods were worsening, and my periods were getting worse. A year after my initial dose of GARDASIL I went back to the doctor and she ran tests for thyroid disease, anemia, etc. to attempt to pinpoint where this was coming from. All the results came back as normal. Five months later symptoms were still heightened. I was sent to an OBGYN where I was then diagnosed with Pre-Menstrual Dysphoric Disorder, put on birth control pills, sertraline and sent to cognitive behavioral therapy. Two years later I am back at the doctors since symptoms still haven't gone away. We did more testing and received normal results. I was the diagnosed with Chronic Fatigue Syndrome since there was no explanation for my muscle aches/joint pain, moods, and hair falling out of my head at only 14 years old. Still to this day, since the first dose of GARDASIL six years ago, I still feel horrible and my symptoms have started affecting my ability to carry out daily activities in my life, with no explanation as to why.
Age: 14.0
Sex: F
Vaccine: HPV9
Symptoms: Blood glucose normal, Blood insulin normal, Blood iron normal, Blood thyroid stimulating hormone normal, Blood triglycerides increased
Clinical narrative: Two weeks after my first dose of the GARDASIL, I started not feeling good. I became extremely irritable and exhausted. This continued and intensified after my second dose. By the time I received the third dose of GARDASIL, my hair was starting to fall out of my head, I was getting joint pain and muscle aches, moods were worsening, and my periods were getting worse. A year after my initial dose of GARDASIL I went back to the doctor and she ran tests for thyroid disease, anemia, etc. to attempt to pinpoint where this was coming from. All the results came back as normal. Five months later symptoms were still heightened. I was sent to an OBGYN where I was then diagnosed with Pre-Menstrual Dysphoric Disorder, put on birth control pills, sertraline and sent to cognitive behavioral therapy. Two years later I am back at the doctors since symptoms still haven't gone away. We did more testing and received normal results. I was the diagnosed with Chronic Fatigue Syndrome since there was no explanation for my muscle aches/joint pain, moods, and hair falling out of my head at only 14 years old. Still to this day, since the first dose of GARDASIL six years ago, I still feel horrible and my symptoms have started affecting my ability to carry out daily activities in my life, with no explanation as to why.
Age: 14.0
Sex: F
Vaccine: HPV9
Symptoms: Chronic fatigue syndrome, Differential white blood cell count normal, Fatigue, Feeling abnormal, Full blood count normal
Clinical narrative: Two weeks after my first dose of the GARDASIL, I started not feeling good. I became extremely irritable and exhausted. This continued and intensified after my second dose. By the time I received the third dose of GARDASIL, my hair was starting to fall out of my head, I was getting joint pain and muscle aches, moods were worsening, and my periods were getting worse. A year after my initial dose of GARDASIL I went back to the doctor and she ran tests for thyroid disease, anemia, etc. to attempt to pinpoint where this was coming from. All the results came back as normal. Five months later symptoms were still heightened. I was sent to an OBGYN where I was then diagnosed with Pre-Menstrual Dysphoric Disorder, put on birth control pills, sertraline and sent to cognitive behavioral therapy. Two years later I am back at the doctors since symptoms still haven't gone away. We did more testing and received normal results. I was the diagnosed with Chronic Fatigue Syndrome since there was no explanation for my muscle aches/joint pain, moods, and hair falling out of my head at only 14 years old. Still to this day, since the first dose of GARDASIL six years ago, I still feel horrible and my symptoms have started affecting my ability to carry out daily activities in my life, with no explanation as to why.
Age: 14.0
Sex: F
Vaccine: HPV9
Symptoms: Haemoglobin normal, Iron binding capacity total normal, Irritability, Laboratory test normal, Lipids normal
Clinical narrative: Two weeks after my first dose of the GARDASIL, I started not feeling good. I became extremely irritable and exhausted. This continued and intensified after my second dose. By the time I received the third dose of GARDASIL, my hair was starting to fall out of my head, I was getting joint pain and muscle aches, moods were worsening, and my periods were getting worse. A year after my initial dose of GARDASIL I went back to the doctor and she ran tests for thyroid disease, anemia, etc. to attempt to pinpoint where this was coming from. All the results came back as normal. Five months later symptoms were still heightened. I was sent to an OBGYN where I was then diagnosed with Pre-Menstrual Dysphoric Disorder, put on birth control pills, sertraline and sent to cognitive behavioral therapy. Two years later I am back at the doctors since symptoms still haven't gone away. We did more testing and received normal results. I was the diagnosed with Chronic Fatigue Syndrome since there was no explanation for my muscle aches/joint pain, moods, and hair falling out of my head at only 14 years old. Still to this day, since the first dose of GARDASIL six years ago, I still feel horrible and my symptoms have started affecting my ability to carry out daily activities in my life, with no explanation as to why.
Age: 14.0
Sex: F
Vaccine: HPV9
Symptoms: Loss of personal independence in daily activities, Menstrual disorder, Metabolic function test normal, Mood altered, Myalgia
Clinical narrative: Two weeks after my first dose of the GARDASIL, I started not feeling good. I became extremely irritable and exhausted. This continued and intensified after my second dose. By the time I received the third dose of GARDASIL, my hair was starting to fall out of my head, I was getting joint pain and muscle aches, moods were worsening, and my periods were getting worse. A year after my initial dose of GARDASIL I went back to the doctor and she ran tests for thyroid disease, anemia, etc. to attempt to pinpoint where this was coming from. All the results came back as normal. Five months later symptoms were still heightened. I was sent to an OBGYN where I was then diagnosed with Pre-Menstrual Dysphoric Disorder, put on birth control pills, sertraline and sent to cognitive behavioral therapy. Two years later I am back at the doctors since symptoms still haven't gone away. We did more testing and received normal results. I was the diagnosed with Chronic Fatigue Syndrome since there was no explanation for my muscle aches/joint pain, moods, and hair falling out of my head at only 14 years old. Still to this day, since the first dose of GARDASIL six years ago, I still feel horrible and my symptoms have started affecting my ability to carry out daily activities in my life, with no explanation as to why.
Age: 14.0
Sex: F
Vaccine: HPV9
Symptoms: Premenstrual dysphoric disorder, Serum ferritin normal, Thyroxine free normal, Tri-iodothyronine normal
Clinical narrative: Two weeks after my first dose of the GARDASIL, I started not feeling good. I became extremely irritable and exhausted. This continued and intensified after my second dose. By the time I received the third dose of GARDASIL, my hair was starting to fall out of my head, I was getting joint pain and muscle aches, moods were worsening, and my periods were getting worse. A year after my initial dose of GARDASIL I went back to the doctor and she ran tests for thyroid disease, anemia, etc. to attempt to pinpoint where this was coming from. All the results came back as normal. Five months later symptoms were still heightened. I was sent to an OBGYN where I was then diagnosed with Pre-Menstrual Dysphoric Disorder, put on birth control pills, sertraline and sent to cognitive behavioral therapy. Two years later I am back at the doctors since symptoms still haven't gone away. We did more testing and received normal results. I was the diagnosed with Chronic Fatigue Syndrome since there was no explanation for my muscle aches/joint pain, moods, and hair falling out of my head at only 14 years old. Still to this day, since the first dose of GARDASIL six years ago, I still feel horrible and my symptoms have started affecting my ability to carry out daily activities in my life, with no explanation as to why.
Age: 0.08
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC13, DTAPHEPBIP, HIBV, PNC13
Symptoms: Apnoea, Bradycardia, Continuous positive airway pressure, Cyanosis, Mechanical ventilation
Clinical narrative: Patient became apneic, cyanotic, and had bradycardia into 40s. O2sats less than 10%. Infant did not respond to stimulation. PPV started at 100% FiO2. CPAP initiated and continued. Infant placed on NIPPV at 0700 2/18.
Age: 0.08
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC13, DTAPHEPBIP, HIBV, PNC13
Symptoms: Oxygen saturation decreased, Unresponsive to stimuli
Clinical narrative: Patient became apneic, cyanotic, and had bradycardia into 40s. O2sats less than 10%. Infant did not respond to stimulation. PPV started at 100% FiO2. CPAP initiated and continued. Infant placed on NIPPV at 0700 2/18.
Age: 0.08
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC13, DTAPHEPBIP, HIBV, PNC13
Symptoms: Bradycardia, Dyspnoea, Intermittent positive pressure breathing, Oxygen saturation decreased, Sleep apnoea syndrome
Clinical narrative: Patient became apneic, cyanotic, and had bradycardia into 40s. O2sats less than 10%. Infant did not respond to stimulation. PPV started at 100% FiO2. CPAP initiated and continued. Infant placed on NIPPV at 0700 2/18.
Age: 0.08
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC13, DTAPHEPBIP, HIBV, PNC13
Symptoms: Unresponsive to stimuli
Clinical narrative: Patient became apneic, cyanotic, and had bradycardia into 40s. O2sats less than 10%. Infant did not respond to stimulation. PPV started at 100% FiO2. CPAP initiated and continued. Infant placed on NIPPV at 0700 2/18.
Age: 0.08
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC13, HIBV, DTAPHEPBIP, HIBV, PNC13
Symptoms: Apnoeic attack, Blood pH decreased, Blood potassium increased, Calcium ionised, Chest X-ray abnormal
Clinical narrative: Patient had apneic event, was intubated, and transferred to hospital. Per note from RT on 2/18 at 1913. - "1230 this afternoon transport team arrived to transport patient to hospital for PDA ligation. Patient was stable at this time on 5cm 21% bubble CPAP. When transport team removed Patient from CPAP and placed on transport CPAP with Ram canula Sats dropped and baby did not tolerate change. NIPPV mode was also attempted on transport ventilator with no success. Baby was bagged with Neo tee by transport team with no improvement of sats in the teens. MRSOPA was utilized and then switched to self inflating Ambu bag with peep valve with PIP35 and Peep 7 and SpO2 maintaining in 20-30s. Two attempts were then made by NNP with successful intubation on 2nd try with 3.0 ETT at 7.5 cm at gums, Lg leak observed. Lg amt of Blood visualized in airway before any attempts were made at intubation. CXR obtained and showed complete white out. Baby was then placed on APV CMV mode on transport ventilator with no improvement in sats and little to no volumes. PC CMV was then tried and no Vt observed with Sats in the teens. Baby then placed on Flow Interupter by transport team. CBG obtained with PH 6.7 PCO2 >130. 1 unit of PRBC and 1 unit FFP started due to suspected pulmonary hemorrhage. On Flow Interupter pressures gradually increased with final settings MAWP 22, 10 HZ. Life flight was called and asked to switch plans from ground transport to flight. SpO2 finally reached high 80s and 90s briefly. Life flight arrived and while preparing for transition to transport isolette a repeat CXR was obtained and still showing complete whiteout. ABG obtained Ph 7.44 PCO2 34. SpO2s began to decline again and decision made to keep baby here on Oscillator and try to stabilize. SpO2s in low 30s again. Baby placed on 3100 A oscillator and MAWP gradually increased from 16-22 over period of time with Delta P eventually topping out at 44 with 10 HZ. Sats still in 20s and 30s and very poor chest wiggle. Nitric ordered by Dr. and 2nd RT began preparing Nitric to be placed on baby. Dr. decided to reintubate with larger tube due to large leak, poor chest wiggle and poor saturations. Dr. had sucessful intubation at 1620 with one attempt. 3.5 ETT taped at 8cm at gums. Very small leak heard. Repeat CXR shows good placement. Placed back on 3100 A with MAWP 22 Delta P 40 and 8 HZ with 100% FiO2 and sats began to climb to 60s and 70s. Nitric Oxide started at 1635 at 20 ppm and sats steadily improving to 80s and low 90s."
Age: 0.08
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC13, HIBV, DTAPHEPBIP, HIBV, PNC13
Symptoms: Continuous positive airway pressure, Endotracheal intubation, Haematocrit decreased, Haemoglobin decreased, Mechanical ventilation
Clinical narrative: Patient had apneic event, was intubated, and transferred to hospital. Per note from RT on 2/18 at 1913. - "1230 this afternoon transport team arrived to transport patient to hospital for PDA ligation. Patient was stable at this time on 5cm 21% bubble CPAP. When transport team removed Patient from CPAP and placed on transport CPAP with Ram canula Sats dropped and baby did not tolerate change. NIPPV mode was also attempted on transport ventilator with no success. Baby was bagged with Neo tee by transport team with no improvement of sats in the teens. MRSOPA was utilized and then switched to self inflating Ambu bag with peep valve with PIP35 and Peep 7 and SpO2 maintaining in 20-30s. Two attempts were then made by NNP with successful intubation on 2nd try with 3.0 ETT at 7.5 cm at gums, Lg leak observed. Lg amt of Blood visualized in airway before any attempts were made at intubation. CXR obtained and showed complete white out. Baby was then placed on APV CMV mode on transport ventilator with no improvement in sats and little to no volumes. PC CMV was then tried and no Vt observed with Sats in the teens. Baby then placed on Flow Interupter by transport team. CBG obtained with PH 6.7 PCO2 >130. 1 unit of PRBC and 1 unit FFP started due to suspected pulmonary hemorrhage. On Flow Interupter pressures gradually increased with final settings MAWP 22, 10 HZ. Life flight was called and asked to switch plans from ground transport to flight. SpO2 finally reached high 80s and 90s briefly. Life flight arrived and while preparing for transition to transport isolette a repeat CXR was obtained and still showing complete whiteout. ABG obtained Ph 7.44 PCO2 34. SpO2s began to decline again and decision made to keep baby here on Oscillator and try to stabilize. SpO2s in low 30s again. Baby placed on 3100 A oscillator and MAWP gradually increased from 16-22 over period of time with Delta P eventually topping out at 44 with 10 HZ. Sats still in 20s and 30s and very poor chest wiggle. Nitric ordered by Dr. and 2nd RT began preparing Nitric to be placed on baby. Dr. decided to reintubate with larger tube due to large leak, poor chest wiggle and poor saturations. Dr. had sucessful intubation at 1620 with one attempt. 3.5 ETT taped at 8cm at gums. Very small leak heard. Repeat CXR shows good placement. Placed back on 3100 A with MAWP 22 Delta P 40 and 8 HZ with 100% FiO2 and sats began to climb to 60s and 70s. Nitric Oxide started at 1635 at 20 ppm and sats steadily improving to 80s and low 90s."
Age: 0.08
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC13, HIBV, DTAPHEPBIP, HIBV, PNC13
Symptoms: Oxygen saturation decreased, PCO2 increased, PO2 decreased, Packed red blood cell transfusion, Pulmonary haemorrhage
Clinical narrative: Patient had apneic event, was intubated, and transferred to hospital. Per note from RT on 2/18 at 1913. - "1230 this afternoon transport team arrived to transport patient to hospital for PDA ligation. Patient was stable at this time on 5cm 21% bubble CPAP. When transport team removed Patient from CPAP and placed on transport CPAP with Ram canula Sats dropped and baby did not tolerate change. NIPPV mode was also attempted on transport ventilator with no success. Baby was bagged with Neo tee by transport team with no improvement of sats in the teens. MRSOPA was utilized and then switched to self inflating Ambu bag with peep valve with PIP35 and Peep 7 and SpO2 maintaining in 20-30s. Two attempts were then made by NNP with successful intubation on 2nd try with 3.0 ETT at 7.5 cm at gums, Lg leak observed. Lg amt of Blood visualized in airway before any attempts were made at intubation. CXR obtained and showed complete white out. Baby was then placed on APV CMV mode on transport ventilator with no improvement in sats and little to no volumes. PC CMV was then tried and no Vt observed with Sats in the teens. Baby then placed on Flow Interupter by transport team. CBG obtained with PH 6.7 PCO2 >130. 1 unit of PRBC and 1 unit FFP started due to suspected pulmonary hemorrhage. On Flow Interupter pressures gradually increased with final settings MAWP 22, 10 HZ. Life flight was called and asked to switch plans from ground transport to flight. SpO2 finally reached high 80s and 90s briefly. Life flight arrived and while preparing for transition to transport isolette a repeat CXR was obtained and still showing complete whiteout. ABG obtained Ph 7.44 PCO2 34. SpO2s began to decline again and decision made to keep baby here on Oscillator and try to stabilize. SpO2s in low 30s again. Baby placed on 3100 A oscillator and MAWP gradually increased from 16-22 over period of time with Delta P eventually topping out at 44 with 10 HZ. Sats still in 20s and 30s and very poor chest wiggle. Nitric ordered by Dr. and 2nd RT began preparing Nitric to be placed on baby. Dr. decided to reintubate with larger tube due to large leak, poor chest wiggle and poor saturations. Dr. had sucessful intubation at 1620 with one attempt. 3.5 ETT taped at 8cm at gums. Very small leak heard. Repeat CXR shows good placement. Placed back on 3100 A with MAWP 22 Delta P 40 and 8 HZ with 100% FiO2 and sats began to climb to 60s and 70s. Nitric Oxide started at 1635 at 20 ppm and sats steadily improving to 80s and low 90s."
Age: 0.08
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC13, HIBV, DTAPHEPBIP, HIBV, PNC13
Symptoms: Transfusion
Clinical narrative: Patient had apneic event, was intubated, and transferred to hospital. Per note from RT on 2/18 at 1913. - "1230 this afternoon transport team arrived to transport patient to hospital for PDA ligation. Patient was stable at this time on 5cm 21% bubble CPAP. When transport team removed Patient from CPAP and placed on transport CPAP with Ram canula Sats dropped and baby did not tolerate change. NIPPV mode was also attempted on transport ventilator with no success. Baby was bagged with Neo tee by transport team with no improvement of sats in the teens. MRSOPA was utilized and then switched to self inflating Ambu bag with peep valve with PIP35 and Peep 7 and SpO2 maintaining in 20-30s. Two attempts were then made by NNP with successful intubation on 2nd try with 3.0 ETT at 7.5 cm at gums, Lg leak observed. Lg amt of Blood visualized in airway before any attempts were made at intubation. CXR obtained and showed complete white out. Baby was then placed on APV CMV mode on transport ventilator with no improvement in sats and little to no volumes. PC CMV was then tried and no Vt observed with Sats in the teens. Baby then placed on Flow Interupter by transport team. CBG obtained with PH 6.7 PCO2 >130. 1 unit of PRBC and 1 unit FFP started due to suspected pulmonary hemorrhage. On Flow Interupter pressures gradually increased with final settings MAWP 22, 10 HZ. Life flight was called and asked to switch plans from ground transport to flight. SpO2 finally reached high 80s and 90s briefly. Life flight arrived and while preparing for transition to transport isolette a repeat CXR was obtained and still showing complete whiteout. ABG obtained Ph 7.44 PCO2 34. SpO2s began to decline again and decision made to keep baby here on Oscillator and try to stabilize. SpO2s in low 30s again. Baby placed on 3100 A oscillator and MAWP gradually increased from 16-22 over period of time with Delta P eventually topping out at 44 with 10 HZ. Sats still in 20s and 30s and very poor chest wiggle. Nitric ordered by Dr. and 2nd RT began preparing Nitric to be placed on baby. Dr. decided to reintubate with larger tube due to large leak, poor chest wiggle and poor saturations. Dr. had sucessful intubation at 1620 with one attempt. 3.5 ETT taped at 8cm at gums. Very small leak heard. Repeat CXR shows good placement. Placed back on 3100 A with MAWP 22 Delta P 40 and 8 HZ with 100% FiO2 and sats began to climb to 60s and 70s. Nitric Oxide started at 1635 at 20 ppm and sats steadily improving to 80s and low 90s."